Cara Therapeutics
CARA
#10367
Rank
S$10.51 M
Marketcap
S$6.89
Share price
-2.56%
Change (1 day)
1,807.59%
Change (1 year)

Cara Therapeutics (CARA) - Net assets

Net assets on the balance sheet as of December 2024 : -S$5.96 Million

According to Cara Therapeutics 's latest financial reports the company has -S$5.96 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Cara Therapeutics - Net assets on balance sheet (from 2012 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$-S$6.25 Million-108.28%
2023-12-31$S$75.39 M-64.58%
2022-12-31$S$0.21 B-30.8%
2021-12-31$S$0.30 B-6.63%
2020-12-31$S$0.32 B30.86%
2019-12-31$S$0.25 B37.89%
2018-12-31$S$0.18 B57.29%
2017-12-31$S$0.11 B58.1%
2016-12-31$S$73.41 M-50.59%
2015-12-31$S$0.14 B117.67%
2014-12-31$S$68.26 M368.06%
2013-12-31$S$14.58 M388.97%
2012-12-31$S$2.98 M-62.27%
2011-12-31$S$7.9 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Trevena
TRVN
-S$30.21 Million 407.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
S$18.27 M-407.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$120.64 B-2,027,010.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$102.73 B-1,726,139.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-S$0.25 Billion 3,944.65%๐Ÿ‡บ๐Ÿ‡ธ USA